Next-Generation Sequencing

CD Genomics

Learn more about Sequencing-based Approaches for Profiling DNA Methylation at CD Genomics: https://www.cd-genomics.com/

Sequencing-based Approaches for Profiling DNA Methylation

Learn more about SNP Genotyping Technologies at CD Genomics: https://www.cd-genomics.com/

SNP Genotyping Technologies

Teach Me in 10

When applying genetics to the study of COVID-19, scientists are learning a lot. Our DNA codes for proteins, some of which are required for SARS-CoV-2 to interact with and infect a host cell, others that are implicated in the downstream effects of viral infection, such as inflammatory responses. But how do scientists choose which genes to study? 

A new study by Dr Thomas Stoeger, a postdoc at North Western University, suggests there is a historical bias involved: scientists are studying human genes that have already been heavily investigated, independent of COVID-19. 
In this installment of Teach Me in 10, Stoeger expands on the key points of this study and the implications of bias in scientific research.

Full research publication: [url][link]https://elifesciences.org/articles/61981[/link][name]Meta-Research: COVID-19 research risks ignoring important host genes due to pre-established research patterns.[/name][/url]


Teach Me in 10 - Why COVID-19 Genetics Research May Be Biased With Dr Thomas Stoeger

Biotech Videos 

Next Generation Sequencing (NGS) is a powerful platform that has enabled the sequencing of thousands to millions of DNA molecules simultaneously. 
Creative Biolabs has developed the SuPrecision™ platform that integrates advanced technology to provide the most in-depth cancer NGS services, which is committed to assisting in accelerating precision medical research and cancer diagnosis.
This video briefly introduces NGS related information. If you need more information about NGS, please follow us. https://www.creative-biolabs.com/suprecision/

NGS Introduction- Creative Biolabs

Creative Biolabs recently has unprecedentedly achieved the precise identification of leucine and isoleucine by mass spectrometry, advancing breakthrough science on protein/antibody sequencing in research, diagnostic, and therapeutic industries. The discrimination of leucine and isoleucine has long been the key technical difficulties of de novo antibody sequencing. However, Creative Biolabs just took a massive leap forward into the new era of this field, with unchallenged ability to achieve 100% accuracy in antibody sequencing by precisely distinguishing between leucine and isoleucine, based on the proprietary Database Assisted Shotgun Sequencing (DASS) technology. https://www.creative-biolabs.com/next-generation-antibody-sequencing.html

Unequivocal Discrimination of Leucine and Isoleucine in De Novo Antibody Sequencing

Microsatellite Genotyping at CD Genomics. Learn more information about Microsatellite Genotyping at https://www.cd-genomics.com/

Microsatellite Genotyping at CD Genomics

Learn More About Epigenetic Modifications & Epigenomic Technologies at CD Genomics: https://www.cd-genomics.com/

Epigenetic Modifications and Epigenomic Technologies

CD Genomics is committed to providing novel NGS services enabling researchers to explore structure and function of the microbial community in a high-resolution and culture-independent manner using technology from Illumina and PacBio. In addition, we also offer the service to sequence the genome of the individual cultured bacteria, fungi, phage or virus, whether do novo or re-sequencing.  https://www.cd-genomics.com/Microbial-Genomics.html

Microbial Genomics

The Development and Workflow of RNA-seq, Learn more at https://www.cd-genomics.com/resourse-Bioinformatics-Workflow-of-RNA-Seq.html

Next-Generation Sequencing

Refine By

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.